LEADER 03659nam 22006735 450 001 9911018761903321 005 20250725130300.0 010 $a9789819683871$b(electronic bk.) 010 $z9789819683864 024 7 $a10.1007/978-981-96-8387-1 035 $a(MiAaPQ)EBC32235806 035 $a(Au-PeEL)EBL32235806 035 $a(CKB)39719244700041 035 $a(DE-He213)978-981-96-8387-1 035 $a(EXLCZ)9939719244700041 100 $a20250725d2025 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aBiosensors and Aptamers $eA New Era in Cancer Diagnosis and Treatment /$fedited by Shriyansh Srivastava, Sachin Kumar, Sathvik Belagodu Sridhar, Malakapogu Ravindra Babu, Shaik Abdul Rahaman 205 $a1st ed. 2025. 210 1$aSingapore :$cSpringer Nature Singapore :$cImprint: Springer,$d2025. 215 $a1 online resource (497 pages) 311 08$aPrint version: Srivastava, Shriyansh Biosensors and Aptamers Singapore : Springer,c2025 9789819683864 327 $a1. Introduction to Biosensors and Aptamers: A New Era in Cancer Diagnosis and Treatment -- 2. The Biology of Cancer: Understanding the Disease and Its Challenges -- 3. Aptamers: A Novel Class of Targeted Therapeutics -- 4. Role of Biosensors in Transforming Cancer Diagnostics -- 5. Aptamer-Based Biosensors for Cancer Diagnosis -- 6. Targeted Cancer Therapy with Aptamers: A Review on the Current State -- 7. Aptamer-Based Cancer Diagnosis: Emerging updates -- 8. Designing Aptamers for Cancer Diagnosis and Therapy -- 9. Aptamer-Based Biosensors for Cancer Biomarker Detection -- 10. Aptamer-Based Biosensors for Cancer Imaging -- 11. Aptamer-Based Biosensors for Cancer Therapy Monitoring -- 12. Challenges and Limitations in Aptamer-Based Cancer Diagnosis and Therapy -- 13. Future Directions in Aptamer-Based Cancer Diagnosis and Therapy -- 14. Regulatory Frameworks and Intellectual property rights (IPR) for Aptamer-Based Cancer Diagnosis and Therapy. 330 $aThe book explores the latest advancements in medical and life sciences, revealing the transformative potential of biosensors and aptamers in combating cancer. These cutting-edge technologies revolutionize diagnosis with unprecedented accuracy and early detection of cancer. The chapters cover advancements in targeted therapy, where aptamers deliver personalized treatments with remarkable precision, minimizing side effects and maximizing efficacy. It highlights real-world applications, success stories, and the pursuit of more effective and humane cancer diagnosis and treatment. The book is intended for clinicians and students. 606 $aCancer 606 $aNanomedicine 606 $aOncology 606 $aPharmacology 606 $aPharmacy 606 $aCancer Nanotechnology 606 $aOncology 606 $aPharmacology 606 $aPharmacy 615 0$aCancer. 615 0$aNanomedicine. 615 0$aOncology. 615 0$aPharmacology. 615 0$aPharmacy. 615 14$aCancer Nanotechnology. 615 24$aOncology. 615 24$aPharmacology. 615 24$aPharmacy. 676 $a616.994 676 $a620.5 700 $aSrivastava$b Shriyansh$01835995 701 $aKumar$b Sachin$01771284 701 $aSridhar$b Sathvik Belagodu$01835996 701 $aRavindra Babu$b Malakapogu$01835997 701 $aRahaman$b Shaik Abdul$01835998 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 912 $a9911018761903321 996 $aBiosensors and Aptamers$94413618 997 $aUNINA